DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Komura K, Jeong SH, Hinohara K. et al.
Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression.
Proceedings of the National Academy of Sciences 2016;
113: 6259-6264
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.